Cost-effectiveness of universal HIV testing and treatment: where next?

Affiliations

¹ Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, USA; Center for Global Health, University of Pittsburgh, Pittsburgh, PA, USA; Department of Medicine and Centre for Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town 7505, South Africa; Department of Epidemiology and Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: jbn16@pitt.edu.
² Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
³ Department of Epidemiology and Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
⁴ Ministry of Health, Lusaka, Zambia.
⁵ Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
⁶ Division of Infectious Diseases, Department of Medicine, Washington University, St Louis, MO, USA; Center for Dissemination and Implementation, Institute for Public Health, Washington University, St Louis, MO, USA.

Comment

Jean B Nachega et al. Lancet Glob Health. 2021 May.

. 2021 May;9(5):e573-e574.

doi: 10.1016/S2214-109X(21)00089-9. Epub 2021 Mar 12.

¹ Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, USA; Center for Global Health, University of Pittsburgh, Pittsburgh, PA, USA; Department of Medicine and Centre for Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town 7505, South Africa; Department of Epidemiology and Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: jbn16@pitt.edu.
² Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
³ Department of Epidemiology and Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
⁴ Ministry of Health, Lusaka, Zambia.
⁵ Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
⁶ Division of Infectious Diseases, Department of Medicine, Washington University, St Louis, MO, USA; Center for Dissemination and Implementation, Institute for Public Health, Washington University, St Louis, MO, USA.

No abstract available

Comment on

Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
Thomas R, Probert WJM, Sauter R, Mwenge L, Singh S, Kanema S, Vanqa N, Harper A, Burger R, Cori A, Pickles M, Bell-Mandla N, Yang B, Bwalya J, Phiri M, Shanaube K, Floyd S, Donnell D, Bock P, Ayles H, Fidler S, Hayes RJ, Fraser C, Hauck K; HPTN 071 (PopART) study team. Thomas R, et al. Lancet Glob Health. 2021 May;9(5):e668-e680. doi: 10.1016/S2214-109X(21)00034-6. Epub 2021 Mar 12. Lancet Glob Health. 2021. PMID: 33721566 Free PMC article.

1. Iwuji CC, Orne-Gliemann J, Larmarange J, et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV 2018; 5: e116–25. - PubMed
1. Hayes RJ, Donnell D, Floyd S, et al. Effect of universal testing and treatment on HIV incidence—HPTN 071 (PopART). N Engl J Med 2019; 381: 207–18. - PMC - PubMed
1. Thomas R, Probert WJM, Sauter R, et al. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial. Lancet Glob Health 2021; published online March 12. 10.1016/S2214-109X(21)00034-6. - DOI - PMC - PubMed
1. Ochalek J, Lomas J, Claxton K. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data. BMJ Glob Health 2018; 3: e000964. - PMC - PubMed
1. Robinson LA, Hammitt JK, Chang AY, Resch S. Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds. Health Policy Plan 2017; 32: 141–45. - PubMed